LRRK2 and Parkinson disease: This suggests that altered LRRK2 activity is involved in PD pathogenesis, which is supported by the fact that most pathogenic mutations (N1437H, R1441C/G/H, Y1699C, G2019S, and I2020T) display increased LRRK2 kinase activity in cells and in vivo [13–16].